1. Home
  2. ACXP vs IFBD Comparison

ACXP vs IFBD Comparison

Compare ACXP & IFBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • IFBD
  • Stock Information
  • Founded
  • ACXP 2017
  • IFBD 2001
  • Country
  • ACXP United States
  • IFBD China
  • Employees
  • ACXP N/A
  • IFBD N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • IFBD Computer Software: Prepackaged Software
  • Sector
  • ACXP Health Care
  • IFBD Technology
  • Exchange
  • ACXP Nasdaq
  • IFBD Nasdaq
  • Market Cap
  • ACXP 8.4M
  • IFBD 8.4M
  • IPO Year
  • ACXP 2021
  • IFBD 2021
  • Fundamental
  • Price
  • ACXP $0.31
  • IFBD $0.99
  • Analyst Decision
  • ACXP Strong Buy
  • IFBD
  • Analyst Count
  • ACXP 2
  • IFBD 0
  • Target Price
  • ACXP $10.00
  • IFBD N/A
  • AVG Volume (30 Days)
  • ACXP 920.6K
  • IFBD 10.9K
  • Earning Date
  • ACXP 08-12-2025
  • IFBD 01-01-0001
  • Dividend Yield
  • ACXP N/A
  • IFBD N/A
  • EPS Growth
  • ACXP N/A
  • IFBD N/A
  • EPS
  • ACXP N/A
  • IFBD N/A
  • Revenue
  • ACXP N/A
  • IFBD $1,437,848.00
  • Revenue This Year
  • ACXP N/A
  • IFBD N/A
  • Revenue Next Year
  • ACXP N/A
  • IFBD N/A
  • P/E Ratio
  • ACXP N/A
  • IFBD N/A
  • Revenue Growth
  • ACXP N/A
  • IFBD 413.52
  • 52 Week Low
  • ACXP $0.29
  • IFBD $0.89
  • 52 Week High
  • ACXP $2.39
  • IFBD $3.32
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 33.75
  • IFBD 39.66
  • Support Level
  • ACXP $0.30
  • IFBD $1.01
  • Resistance Level
  • ACXP $0.50
  • IFBD $1.04
  • Average True Range (ATR)
  • ACXP 0.05
  • IFBD 0.04
  • MACD
  • ACXP -0.02
  • IFBD -0.01
  • Stochastic Oscillator
  • ACXP 7.86
  • IFBD 3.71

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About IFBD Infobird Co. Ltd

Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.

Share on Social Networks: